TY  - GEN
AU  - Kozuka,Chisayo
AU  - Shimizu-Okabe,Chigusa
AU  - Takayama,Chitoshi
AU  - Nakano,Kaku
AU  - Morinaga,Hidetaka
AU  - Kinjo,Ayano
AU  - Fukuda,Kotaro
AU  - Kamei,Asuka
AU  - Yasuoka,Akihito
AU  - Kondo,Takashi
AU  - Abe,Keiko
AU  - Egashira,Kensuke
AU  - Masuzaki,Hiroaki
TI  - Marked augmentation of PLGA nanoparticle-induced metabolically beneficial impact of γ-oryzanol on fuel dyshomeostasis in genetically obese-diabetic ob/ob mice
SN  - 1521-0464
PY  - 2017///0403
KW  - Administration, Oral
KW  - Animals
KW  - Behavior, Animal
KW  - drug effects
KW  - Blood Glucose
KW  - Diabetes Mellitus
KW  - blood
KW  - Disease Models, Animal
KW  - Dose-Response Relationship, Drug
KW  - Drug Administration Schedule
KW  - Drug Carriers
KW  - Drug Compounding
KW  - Endoplasmic Reticulum Stress
KW  - Energy Metabolism
KW  - Food Preferences
KW  - Gastrointestinal Microbiome
KW  - Hypoglycemic Agents
KW  - administration & dosage
KW  - Hypolipidemic Agents
KW  - Insulin Resistance
KW  - Intestinal Absorption
KW  - Islets of Langerhans
KW  - Lactic Acid
KW  - Lipids
KW  - Liver
KW  - Male
KW  - Mice, Obese
KW  - Nanomedicine
KW  - Nanoparticles
KW  - Obesity
KW  - Phenylpropionates
KW  - Polyglycolic Acid
KW  - Polylactic Acid-Polyglycolic Acid Copolymer
KW  - Solubility
KW  - Technology, Pharmaceutical
KW  - methods
KW  - Time Factors
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1080/10717544.2017.1279237
ER  -